<DOC>
	<DOCNO>NCT01440673</DOCNO>
	<brief_summary>- Gynecological surgery associate high incidence postoperative nausea vomit . - NK1 receptor antagonist aprepitant appear highly effective treat acute delay emesis , yet understand efficacy different dos aprepitant limit . - We perform prospective , randomize , double-blinded placebo-controlled study 123 female adult schedule laparoscopic hysterectomy receive 80 mg aprepitant , 125 mg aprepitant , placebo .</brief_summary>
	<brief_title>Aprepitant Postoperative Nausea Vomiting Laparoscopic Hysterectomy</brief_title>
	<detailed_description>123 female patient ( age 21-60 ) undergo laparoscopic hysterectomy 1 . 80mg aprepitant 2 . 125mg aprepitant 3. placebo Incidences nausea , vomiting/retching , use rescue antiemetic record 0 , 1 , 2 , 24 , 48 h surgery .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<criteria>female laparoscopic hysterectomy isoflurane anesthesia postoperative opioid use liver disease neurologic disease active pulmonary disease cardiac arrhythmia allergy perioperative medication</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Postoperative Nausea Vomiting</keyword>
</DOC>